Search Menu
Photonics Media Photonics Buyers' Guide Photonics Spectra BioPhotonics EuroPhotonics Vision Spectra Photonics Showcase Photonics ProdSpec Photonics Handbook
More News

Consortium Formed to Create Artificial Tissue

Facebook Twitter LinkedIn Email Comments
AACHEN, Germany, Jan. 26, 2012 — Under the leadership of Fraunhofer Institute for Laser Technology ILT, a consortium of 16 European partners from the medical industry and research community has been established to generate artificial tissue for implants under the project ArtiVasc 3-D.

One of the biggest challenges in the medical industry has been to create multilayer tissue structures designed to diffuse nutrients for surrounding cells in a similar manner to natural tissue.

The ArtiVasc 3-D project team at Fraunhofer Institute for Laser Technology ILT in Aachen. (Image: Fraunhofer ILT, Aachen)

The consortium will develop a process of engineering artificial tissues with a blood supply similar to those in natural arteries.

Fraunhofer ILT held the kickoff meeting for the project in late November. ArtiVasc 3-D received €7.8 million (about $10.3 million) in funding from the European Commission under the Seventh Framework Programme.

Using current technologies, skin grafts that do not require vascularization cannot be grown beyond a surface area of 1 cm2 and a thickness of 1 to 2 mm. For larger and thicker areas of tissue, vascularization is necessary.

Over the next four years, the consortium will combine technologies from the fields of additive manufacturing and biofunctionalization to develop a process capable of engineering blood vessels in an artificial scaffold system. These vascularized scaffolds will be populated with autologous cells to formulate vascularized fatty tissue and, ultimately, artificial skin. The artificial skin will be used as an in vitro test system — for example, to reduce the number of animal experiments — and be employed directly in skin grafts.

For more information, visit:
Jan 2012
additive manufacturingartificial tissue generationArtiVasc 3-DbiofunctionalizationBiophotonicsBusinessEuropeEuropean CommissionFraunhofer ILTFraunhofer Institute for Laser Technology ILTGermanyindustrialmultilayer tissue structuresSeventh Framework Programmevascularizationlasers

back to top
Facebook Twitter Instagram LinkedIn YouTube RSS
©2019 Photonics Media, 100 West St., Pittsfield, MA, 01201 USA,

Photonics Media, Laurin Publishing
x We deliver – right to your inbox. Subscribe FREE to our newsletters.
We use cookies to improve user experience and analyze our website traffic as stated in our Privacy Policy. By using this website, you agree to the use of cookies unless you have disabled them.